#151228

Anti-HLADQ1 [TAL 4.1]

Cat. #151228

Anti-HLADQ1 [TAL 4.1]

Cat. #: 151228

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 1-2 weeks

Target: Human Leukocyte Antigen DQ1 (includes DQ5 and 6 )

Class: Monoclonal

Application: ELISA ; FACS ; IHC ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-HLADQ1 [TAL 4.1]
  • Clone: TAL 4.1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 28 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; FACS ; IHC ; WB
  • Description: TAL 4.1 can be used for tissue typing and detection of class II products.
  • Immunogen: Whole cells from the B line WT46
  • Isotype: IgG2b
  • Myeloma used: P3/NS1/1-Ag4.1

Target Details

  • Target: Human Leukocyte Antigen DQ1 (includes DQ5 and 6 )
  • Molecular weight: 28 kDa
  • Target background: Human Leukocyte Antigens (HLA) are highly polymorphic proteins that are involved in the presentation of antigens to the T-cell receptor. There are two classes of HLA antigens, class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D).

Applications

  • Application: ELISA ; FACS ; IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Kanangat et al. 2018. Hum Immunol. 79(7):558-563. PMID: 29656111.
  • Bodmer et al. 1984. Br Med Bull. 40(3):267-75. PMID: 6205714.